A. Dohchin et al., Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma, CANCER, 89(3), 2000, pp. 482-487
BACKGROUND. With the recent development of minimal treatment for early stag
e gastric carcinoma, identifying specific indicators of the metastatic pote
ntial of primary tumors has become more important. Cathepsin B and cathepsi
n L, both lysosomal cysteine proteases, degrade the extracellular matrix du
ring tumor progression. Although many studies have shown their relation to
human cancer progression, little is known about their roles in the early st
age. The clinicopathologic significance of cathepsins was therefore studied
in early stage gastric carcinoma.
METHODS. Expression of both cathepsins was studied immunohistochemically in
51 tissue specimens from gastric carcinomas that invaded the submucosal la
yer or muscularis propria. The relation between their expression and clinic
opathologic factors was analyzed.
RESULTS. Both cathepsins were expressed at higher levels in tumors that inv
aded the muscularis propria than in those within the submucosa (P < 0.05).
In addition, tumors with lymphatic invasion showed higher cathepsin B expre
ssion than those without it (P < 0.05), whereas tumors with Venous invasion
showed higher cathepsin L expression than those without it (P < 0.05). No
other clinicopathologic factors correlated with expression of either cathep
sin.
CONCLUSIONS. Tumors with overexpression of cathepsins have powerful potenti
al for invasiveness in the early stage of gastric carcinoma. Moreover, the
authors hypothesize that cathepsins may be one of the determinants of the m
etastatic route. To the authors' knowledge, this is the first report on spe
cific proteases concerning the mode of metastasis, and the results of this
study suggest that therapeutic strategies for early stage gastric carcinoma
might need to be changed according to the status of cathepsins. (C) 2000 A
merican Cancer Society.